Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: JAMA Cardiol. 2017 Mar 1;2(3):260–267. doi: 10.1001/jamacardio.2016.5139

Table 2.

Cardiovascular disease risk factors among HIV-infected individuals with MI by MI type (T1MI vs. T2MI)

Characteristic T1MI*
N=362
N (%)
T2MI
N=288
N (%)
P-value

Diabetes (N, %) 0.5

No 286 (79) 221 (77)
Yes 76 (21) 67 (23)

Blood pressure mean (mean, SD) 0.3

Systolic (mmHg) 132 (23) 130 (24)

Anti-hypertensive medication (N, %) 0.6

No 164 (45) 124 (43)
Yes 198 (55) 164 (57)

Lipid Levels mean (mean, SD)

HDL (mg/dL) 40 (15) 42 (19) 0.2
LDL (mg/dL) 108 (43) 87 (40) <0.001
Non-HDL (mg/dL) 149 (52) 125 (60) <0.001
Total Cholesterol (mg/dL) 190 (54) 167 (63) <0.001
Triglycerides (mg/dL) 227 (182) 208 (272) 0.4

Statin use (N, %) <0.001

No 244 (67) 232 (81)
Yes 118 (33) 56 (19)

Smoking (N, %) 0.005

No 125 (35) 136 (47)
Former 56 (15) 36 (13)
Current 181 (50) 116 (40)

Body mass index (mean, SD)

BMI (kg/m2) 26 (5) 24 (6) 0.001

Risk Score (mean, SD) <0.001

Framingham CHD (% 10 year event risk) 10 (8) 8 (7)
*

T1MI also include cardiac interventions such as coronary artery bypass graft (CABG) surgery

HDL: high density lipoprotein cholesterol; LDL: low density lipoprotein cholesterol; non-HDL; non-high density lipoprotein cholesterol